Trial Watch: Monoclonal antibodies in cancer therapy

Since the advent of hybridoma technology, dating back to 1975, monoclonal antibodies have become an irreplaceable diagnostic and therapeutic tool for a wide array of human diseases. During the last 15 years, several monoclonal antibodies (mAbs) have been approved by FDA for cancer therapy. These mAb...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Galluzzi, Lorenzo, Vacchelli, Erika, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zucman-Rossi, Jessica, Zitvogel, Laurence, Kroemer, Guido
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2012
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376976/
https://ncbi.nlm.nih.gov/pubmed/22720209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.1.1.17938
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items